Literature DB >> 12412667

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey.

S Rennard1, M Decramer, P M A Calverley, N B Pride, J B Soriano, P A Vermeire, J Vestbo.   

Abstract

To date, no international surveys estimating the burden of chronic obstructive pulmonary disease (COPD) in the general population have been published. The Confronting COPD International Survey aimed to quantify morbidity and burden in COPD subjects in 2000. From a total of 201,921 households screened by random-digit dialling in the USA, Canada, France, Italy, Germany, The Netherlands, Spain and the UK, 3,265 subjects with a diagnosis of COPD, chronic bronchitis or emphysema, or with symptoms of chronic bronchitis, were identified. The mean age of the subjects was 63.3 yrs and 44.2% were female. Subjects with COPD in North America and Europe appear to underestimate their morbidity, as shown by the high proportion of subjects with limitations to their basic daily life activities, frequent work loss (45.3% of COPD subjects of <65 yrs reported work loss in the past year) and frequent use of health services (13.8% of subjects required emergency care in the last year), and may be undertreated. There was a significant disparity between subjects' perception of disease severity and the degree of severity indicated by an objective breathlessness scale. Of those with the most severe breathlessness (too breathless to leave the house), 35.8% described their condition as mild or moderate, as did 60.3% of those with the next most severe degree of breathlessness (breathless after walking a few minutes on level ground). This international survey confirmed the great burden to society and high individual morbidity associated with chronic obstructive pulmonary disease in subjects in North America and Europe.

Entities:  

Mesh:

Year:  2002        PMID: 12412667     DOI: 10.1183/09031936.02.03242002

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  122 in total

1.  Chronic obstructive pulmonary disease in China: the potential role of indacaterol.

Authors:  Jinming Gao; Niyati Prasad
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Functioning and psychological status among individuals with COPD.

Authors:  Patricia P Katz; Mark D Eisner; Edward H Yelin; Laura Trupin; Gillian Earnest; John Balmes; Paul D Blanc
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

Review 3.  Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; M Rutten-Van Mölken; J Buffels; O Van Schayck; P-A Gevenois; R Pellegrino; E Derom; W De Backer
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

Review 4.  Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; P Bartsch; C-G Löfdahl; W Vincken; R Dekhuijzen; J Vestbo; R Pauwels; R Naeije; T Troosters
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

Review 5.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

Review 6.  COPD: what is the unmet need?

Authors:  P M A Calverley
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

7.  Distribution of self-rated health and association with clinical parameters in patients with chronic obstructive pulmonary disease.

Authors:  Jerneja Farkas; Mitja Kosnik; Lijana Zaletel-Kragelj; Matjaz Flezar; Stanislav Suskovic; Mitja Lainscak
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

8.  Associations between symptoms, functioning, and perceptions of mastery with global self-rated health in patients with COPD: a cross-sectional study.

Authors:  Huong Q Nguyen; DorAnne Donesky-Cuenco; Virginia Carrieri-Kohlman
Journal:  Int J Nurs Stud       Date:  2007-11-05       Impact factor: 5.837

9.  Objective Measurement of Cough Frequency During COPD Exacerbation Convalescence.

Authors:  Michael G Crooks; Yvette Hayman; Andrew Innes; James Williamson; Caroline E Wright; Alyn H Morice
Journal:  Lung       Date:  2015-08-18       Impact factor: 2.584

10.  Natural histories of chronic obstructive pulmonary disease.

Authors:  Stephen I Rennard; Jørgen Vestbo
Journal:  Proc Am Thorac Soc       Date:  2008-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.